glp-1 gastric intestinal obstruction law office in west virginia semaglutide gastrointestinal West Virginia patients left in limbo over changing insurance coverage of obesity medications Miami GLP-1 Lawyer - Bursor
Description
doi:10.1111/dom.16376 5
The key is timing
[DOI] [PubMed] [Google Scholar] 160.Liu Y, et al
Of course, I need to note that GLP-1s are only FDA-approved for type 2 diabetes and obesity
The popularity of these medications created a surge in demand, which led to shortages of some GLP-1 receptor agonists that began in 2022
Pathogenesis of Hidradenitis Suppurativa: An Immunological Perspective
